Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Tenofovir-Hiv'
Tenofovir-Hiv published presentations and documents on DocSlides.
The Bangkok Tenofovir Study
by marina-yarberry
An HIV pre-exposure prophylaxis trial in Thailand...
Switching the NRTI Backbone to Tenofovir DF-Emtricitabine
by reese
TOTEM. Switching the NRTI Backbone to Tenofovir DF...
HIV Pharmacotherapy Focused Update
by yoshiko-marsland
Drew Lambert, . PharmD. lambertd@husson.edu. Huss...
HIV Medication Overview
by kittie-lecroy
John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. A...
Simplification to Efavirenz-Tenofovir DF-Emtricitabine
by valerie
ADONE Trial. Simplification to Efavirenz-Tenofovir...
Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine
by kylie
STEAL. Switch NRTIs to Tenofovir DF-Emtricitabine ...
Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi
by conchita-marotz
A.Dravid. 1. ,A.Sadre. 2. ,S.Dhande. 1. , A.Borka...
ART Initiation: PrEP and
by alida-meadow
Treatment-naïve Patients . Clinical Instructor, ...
Conflict of Interest “No conflicts of interest to declare”
by karlyn-bohler
Lessons Learned from Tenofovir Vaginal Gel Studie...
Antiretroviral Updates:
by tatyana-admore
New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...
HIV/AIDS HIV There are two types of HIV virus HIV 1 and HIV 2 ,most cases are caused by type 1 ,t
by phoebe
HIV1 and slower to progress to AIDS.. Most cases a...
Switching from TDF/FTC to TAF/
by fanny
FTC. Study 311-1089. Switching from TDF/FTC to TAF...
Generic tenofovir disoproxil
by SunkissedBabe
fumarate and . emtricitabine. tablets obtained fr...
Major Changes to the HHS Adult and Adolescent HIV Treatment
by tawny-fly
Brian R. Wood, MD. Assistant Professor of Medicin...
State
by pasty-toler
of the evidence from oral and topical . PrEP. ef...
Tenofovir
by alida-meadow
based . PrEP. technologies in women : . what do...
HIV OI's and prophylaxis
by callie
, PEP, PREP . Compiled by Jason Vermaak, . Ektha. ...
HIV in Flux Viruses We’re talking tiny: 110 – 150 nm
by TacoBellDiego
That’s 150 billionths of a meter. The bad guy . ...
HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP
by Powerpixel
Clinical Pharmacist – HIV Medicine. Outline. Wha...
HIV Pharmacotherapy Focused Update
by sherrill-nordquist
Drew Lambert, . PharmD. lambertd@husson.edu. Huss...
2014: HIV, HCV, and HBV
by kittie-lecroy
Update. David Spach, MD. Professor of Medicine,...
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
Pre- and Post-Exposure Prophylaxis for HIV
by stefany-barnette
Kevin L. Ard, MD, MPH. October 20, 2016. Learning...
Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112
by micah
Tenofovir. . Disoproxil. . Fumarate. to . Tenof...
Florida AIDS Drug Assistance
by natalia-silvester
Program. Improving Health. . . Promoting Wellness...
Florida AIDS Drug Assistance
by yoshiko-marsland
Program. Improving Health. . . Promoting Wellness...
New Antiretrovirals for the Treatment
by alida-meadow
of HIV. . Convenience, tolerability, simplicity....
Florida AIDS Drug Assistance
by liane-varnes
Program. Improving Health. . . Promoting Wellness...
CHILDREN AND HIV Fact sheet Children and HIV July Stopping new HIV infections among children As a result of scaledup HIV prevention services there was a decline in the number of new HIV infections
by alexa-scheidler
Despite this signi64257cant progress the number o...
Presenters Kathryn Burnett, PharmD, BCPS, BCIDP
by jade
Madeline Droney, PharmD. In it for the Long-Haul. ...
HBV Clinical Management [TRAINER(S) NAME(S)]
by mia
IAPAC African Regional . Capacity-Building . Hub. ...
Getting the FACTS Right!
by sophie
Update & Scenario Planning for FACTS001 Trial....
HBV Clinical Management [TRAINER(S) NAME(S)] IAPAC African Regional
by mitsue-stanley
HBV Clinical Management [TRAINER(S) NAME(S)] IAPA...
Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of
by briana-ranney
B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Buku...
W orking
by min-jolicoeur
with . Different Groups. Module 3 (f). People who...
Leveraging community and private-sector HIV self-testing to improve access to HIV testing services
by cannon343
The Power of People: Community-based models to imp...
Figure 2 Figure 2. Phylogenetic classification of HIV-1 strains in dually infected patients. HIV-1
by sage394
Pieniazek D, Janini LM, Ramos A, Tanuri A, Schecht...
Co-morbidities In People Living With HIV: Host- Or HIV-Associated
by claire
Lene Ryom. MD PhD. CHIP, Center of Excellence for ...
NOTES: Includes HIV funding provided through State/OGAC, USAID, CDC, NIH, and DoD. Bilateral HIV in
by kylie
FY20 . is based on funding provided in the “Cons...
HIV HIV END ing as an epidemic
by holly
Supporting people who are living with HIV. Prevent...
Load More...
![HBV Clinical Management [TRAINER(S) NAME(S)]](https://thumbs.docslides.com/1038908/hbv-clinical-management-trainer-s-name-s.jpg)
![HBV Clinical Management [TRAINER(S) NAME(S)] IAPAC African Regional](https://thumbs.docslides.com/761285/hbv-clinical-management-trainer-s-name-s-iapac-african-regional.jpg)
